Dr Reddy’s Shares Drop 2.11% After Goldman Sachs Downgrade
Shares of Dr Reddy's Laboratories declined 2.11% to Rs 1,303 on Friday, following cautious commentary from Goldman Sachs and Citigroup. Goldman Sachs downgraded the stock to “Sell” and cut its target price to Rs 1,075…